High Dose Ribavirin and Peginterferon for Chronic Hepatitis C Non-responders or Relapsers

被引：0
|
作者：
Gara, Naveen [1 ]
Abdalla, Adil A. [1 ]
Rivera, Elenita M. [1 ]
Zhao, Xiongce [1 ]
Fryzek, Nancy [1 ]
Noureddin, Mazen [1 ]
Sarkar, Souvik [1 ]
Heller, Theo [1 ]
Rotman, Yaron [1 ]
Doo, Edward [1 ]
Liang, T. Jake [1 ]
Hoofnagle, Jay H. [1 ]
Ghany, Marc G. [1 ]
机构：
[1] NIDDK, NIH, Bethesda, MD USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1836
引用
收藏
页码：1049A / 1049A
页数：1
相关论文
共 50 条
  • [21] High-dose induction with interferon alpha 2b is safe and efficacious in interferon relapsers and non-responders with chronic hepatitis C.
    Ganger, CD
    Conjeevaram, H
    Wiley, T
    Flamm, S
    O'Riordan, K
    GASTROENTEROLOGY, 1998, 114 (04) : A1244 - A1244
  • [22] Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial
    Pessoa, Mario G.
    Cheinquer, Hugo
    Almeida, Paulo R. L.
    Silva, Giovanni F.
    Lima, Maria Patelli J. S.
    Parana, Raymundo
    Lacerda, Marco A.
    Parise, Edison R.
    Pernambuco, Jose R. B.
    Pedrosa, Suelene S.
    Teixeira, Rosangela
    Sette, Hoel, Jr.
    Tatsch, Fernando
    ANNALS OF HEPATOLOGY, 2012, 11 (01) : 52 - 61
  • [23] The renew trial: A national, multicenter study of high-dose peginterferon alfa-2b plus ribavirin for non-responders with hepatitis C.
    Gross, JB
    Therneau, TM
    Johnson, SM
    Kwo, PY
    Afdhal, NH
    Flamm, SL
    HEPATOLOGY, 2003, 38 (04) : 312A - 313A
  • [24] Chronic Hepatitis C: High-dose peginterferon and ribavirin in nonresponders successfully
    Weiss, Johannes
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (11): : 1446 - 1446
  • [25] Eighty-percent fifty two-week virologic response in retreatment of chronic hepatitis C non-responders and responder-relapsers with combination ribavirin and induction: High dose interferon.
    Pimstone, NR
    Canio, JB
    Kao, J
    Kokosinski, J
    Saicheur, T
    HEPATOLOGY, 1999, 30 (04) : 630A - 630A
  • [26] Safety and tolerability of double-dose peginterferon alfa-2b and weight-based ribavirin for non-responders with hepatitis C
    Gross, JB
    Johnson, SM
    Therneau, TM
    Kwo, PY
    Afdhal, NH
    Flamm, SL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S143 - S143
  • [27] The Role of Autophagy in Interferon/Ribavirin Responders and Non-Responders with Hepatitis C Virus Infection
    Abbasi, Fahimeh
    Bamdad, Taravat
    Ghadimi-Moghadam, Abdolkarim
    Chubin, Hamzeh
    Jamalidoust, Marzieh
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2020, 13 (03)
  • [28] Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α
    Tromm, A
    Greving, I
    Hueppe, D
    GASTROENTEROLOGY, 1999, 116 (04) : A834 - A834
  • [29] Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C
    Gambarin-Gelwan, M.
    Jacobson, I. M.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (09) : 623 - 633
  • [30] Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype I chronic hepatitis C patients: proof of concept
    Pardo-Yules, Benjamin
    Gallego-Duran, Rocio
    Eslam, Mohammed
    Garcia-Collado, Carlos
    Grande, Lourdes
    Paradas, Carmen
    Morillo, Ramon
    Dorantes, Benito
    Romero-Gomez, Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (12) : 619 - 625
12345